EMBECTA CORP. Stock-Based Compensation
EMBECTA CORP. (EMBC) reported Stock-Based Compensation of $15.80 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- EMBECTA CORP. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.20M, a 28.81% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $5.70M, a 21.92% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.90M, a 33.71% decline year-over-year.
- EMBECTA CORP. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $9.50M, a 53.23% increase year-over-year.
- EMBECTA CORP. share-based payment arrangement, noncash expense for fiscal 2025 was $31.60M, a 20.15% increase from fiscal 2024.
- EMBECTA CORP. share-based payment arrangement, noncash expense for fiscal 2024 was $26.30M, a 22.33% increase from fiscal 2023.
- EMBECTA CORP. share-based payment arrangement, noncash expense for fiscal 2023 was $21.50M, a 14.97% increase from fiscal 2022.
- EMBECTA CORP. share-based payment arrangement, noncash expense for fiscal 2022 was $18.70M, a 46.09% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $9.90M derived: sum of 2 quarters · filed 2026-08-07 | $15.80M 10-Q · filed 2026-08-07 | $25.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $5.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $11.60M 10-Q · filed 2026-05-05 | $21.10M derived: sum of 3 quarters · filed 2026-05-05 | $27.00M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $5.90M 10-Q · filed 2026-02-05 | $15.40M derived: sum of 2 quarters · filed 2026-02-05 | $21.30M derived: sum of 3 quarters · filed 2026-08-07 | $28.60M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-09-30 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $15.40M derived: sum of 2 quarters · filed 2026-08-07 | $22.70M derived: sum of 3 quarters · filed 2026-08-07 | $31.60M 10-K · filed 2025-11-25 | |
| 2025-06-30 | $5.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-07 | $13.20M derived: sum of 2 quarters · filed 2026-08-07 | $22.10M 10-Q · filed 2026-08-07 | $28.30M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $7.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-05 | $16.20M 10-Q · filed 2026-05-05 | $22.40M derived: sum of 3 quarters · filed 2026-05-05 | $28.70M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $8.90M 10-Q · filed 2026-02-05 | $15.10M derived: sum of 2 quarters · filed 2026-02-05 | $21.40M derived: sum of 3 quarters · filed 2026-02-05 | $27.90M derived: sum of 4 quarters · filed 2026-02-05 | |
| 2024-09-30 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $12.50M derived: sum of 2 quarters · filed 2025-11-25 | $19.00M derived: sum of 3 quarters · filed 2025-11-25 | $26.30M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $6.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | $12.80M derived: sum of 2 quarters · filed 2025-08-08 | $20.10M 10-Q · filed 2025-08-08 | $25.00M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2024-03-31 | $6.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-09 | $13.80M 10-Q · filed 2025-05-09 | $18.70M derived: sum of 3 quarters · filed 2025-11-25 | $24.20M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2023-12-31 | $7.30M 10-Q · filed 2025-02-06 | $12.20M derived: sum of 2 quarters · filed 2025-11-25 | $17.70M derived: sum of 3 quarters · filed 2025-11-25 | $23.30M derived: sum of 4 quarters · filed 2025-11-25 | |
| 2023-09-30 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $10.40M derived: sum of 2 quarters · filed 2025-11-25 | $16.00M derived: sum of 3 quarters · filed 2025-11-25 | $21.50M 10-K · filed 2025-11-25 | |
| 2023-06-30 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $11.10M derived: sum of 2 quarters · filed 2024-08-09 | $16.60M 10-Q · filed 2024-08-09 | $21.00M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2023-03-31 | $5.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $11.10M 10-Q · filed 2024-05-09 | $11.30M 10-Q · filed 2023-05-12 | $15.50M derived: sum of 3 quarters · filed 2024-12-11 | $21.30M derived: sum of 4 quarters · filed 2024-12-11 |
| 2022-12-31 | $5.50M 10-Q · filed 2024-02-09 | $9.90M derived: sum of 2 quarters · filed 2024-12-11 | $15.70M derived: sum of 3 quarters · filed 2024-12-11 | $19.60M derived: sum of 4 quarters · filed 2024-12-11 | |
| 2022-09-30 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-11 | $10.20M derived: sum of 2 quarters · filed 2024-12-11 | $14.10M derived: sum of 3 quarters · filed 2024-12-11 | $18.70M 10-K · filed 2024-12-11 | |
| 2022-06-30 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $9.70M derived: sum of 2 quarters · filed 2023-08-08 | $14.30M 10-Q · filed 2023-08-08 | $17.50M derived: sum of 4 quarters · filed 2023-11-29 | |
| 2022-03-31 | $3.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $8.50M 10-Q · filed 2023-05-12 | $11.70M derived: sum of 3 quarters · filed 2023-11-29 | $14.60M derived: sum of 4 quarters · filed 2023-11-29 | |
| 2021-12-31 | $4.60M 10-Q · filed 2023-02-14 | $7.80M derived: sum of 2 quarters · filed 2023-11-29 | $10.70M derived: sum of 3 quarters · filed 2023-11-29 | $13.60M derived: sum of 4 quarters · filed 2023-11-29 | |
| 2021-09-30 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $6.10M derived: sum of 2 quarters · filed 2023-11-29 | $9.00M derived: sum of 3 quarters · filed 2023-11-29 | $12.80M 10-K · filed 2023-11-29 | |
| 2021-06-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $5.80M derived: sum of 2 quarters · filed 2022-08-15 | $9.60M 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | $6.70M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $3.80M 10-Q · filed 2022-03-16 | ||||
| 2020-09-30 | $12.70M 10-K · filed 2022-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |